Cardiovascular Diseases Clinical Trials in New Haven, Connecticut

4 studies are recruiting for cardiovascular diseases in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

    PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the …

    Stage
    Phase 4
    Ages
    75 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    106 in total
    Run by
    Duke University

    See if you can join NCT04262206 on ClinicalTrials.gov

  2. The Oxford Risk Factors And Non-Invasive Imaging Study

    ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.

    Stage
    Not phased
    Ages
    18 to 99
    Site
    Yale University, School of Medicine, New Haven, Connecticut
    Locations
    45 in total
    Run by
    University of Oxford

    See if you can join NCT05169333 on ClinicalTrials.gov

  3. Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

    VahatiCor's Coronary Sinus Reducer (A-FLUX) has been designed to improve angina or angina-like symptoms in patients with CMD. SERRA-I is an early feasibility study that evaluates the safety and clinical performance of the A-FLUX Reducer in this population.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    3 in total
    Run by
    VahatiCor, Inc.

    See if you can join NCT07449325 on ClinicalTrials.gov

  4. MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…

    Stage
    Not phased
    Ages
    18 to 110
    Site
    Yale University / Yale New Haven Hospital, New Haven, Connecticut
    Locations
    28 in total
    Run by
    Concept Medical Inc.

    See if you can join NCT05908331 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.